Serum metabolite concentrations and decreased GFR in the general population.
about
Integrated genomics and metabolomics in nephrologyGenome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levelsA Metabolomic Approach to Understanding the Metabolic Link between Obesity and DiabetesAssociations between thyroid hormones and serum metabolite profiles in an euthyroid population.Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic studySerum metabolomic profiling and incident CKD among African AmericansUrine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.Genome-wide association study reveals a polymorphism in the podocyte receptor RANK for the decline of renal function in coronary patients.Metabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertensionMetabolomics and renal disease.Novel biomarkers for pre-diabetes identified by metabolomics.Urine Metabolite Profiles Predictive of Human Kidney Allograft Status.A Metabolome-Wide Association Study of Kidney Function and Disease in the General PopulationIdentification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profilingA combined epidemiologic and metabolomic approach improves CKD prediction.Metabolomics insights into pathophysiological mechanisms of nephrology.Metabolomics for clinical use and research in chronic kidney disease.Metabolite markers of incident CKD riskMetabolic signature of CKD: the search continues.L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis.Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.Novel Filtration Markers for GFR Estimation.Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia.From Discovery to Translation: Characterization of C-Mannosyltryptophan and Pseudouridine as Markers of Kidney Function.Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.Familial resemblance for serum metabolite concentrations.Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.A Systems-Level View of Renal Metabolomics.Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.Analysis of purine metabolites in maternal serum for evaluating the risk of gestosis.MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications.Association Between Newborn Metabolic Profiles and Pediatric Kidney Disease.
P2860
Q26823928-3DD9DAC7-E840-4AFF-A722-A883041ECDF8Q27324181-7F4DE779-1BAD-4D15-B049-BEEF0BCBF457Q28083355-F1A17EF3-A4E2-435B-90C1-C609B16FAB34Q33701197-F707E317-44BD-4FA8-B26F-28D8A81B51E2Q33810793-C78DD5EC-36E5-439E-B5F5-EC0427E24DDFQ34008968-9D26339F-1F12-43DD-9E5D-96608263B801Q34411671-1BB31C52-12B2-46C8-BACD-17238518C5B3Q34640574-4ADB218E-3E7A-4C57-A3AB-51F1D2C976EFQ35161725-96C23FD1-18EE-402D-90E7-98CA05344398Q35778649-BCBB8F10-6C6B-4B3A-A207-7CA2222D0CA3Q36321634-06A7F3C2-2556-405C-AEE1-01BB46418AD7Q36514964-C8A3E4AF-3CCE-4916-9514-B6EE73EEE3ACQ36746035-37581C16-0F02-4D46-8C43-92677384A1B1Q36910790-5B28FC23-9DE2-4F3C-803C-502C8EF31237Q37078386-43579C0C-DAFD-41C2-814D-AB10EDCD20F3Q38161822-52605817-AB5F-4DDC-B432-44FD7D5616BAQ38750287-2D3FDED0-BD6C-40EA-AE98-7B131BD90B07Q42772434-55B8A73F-BF5D-4B99-8A6C-E61839DBFB86Q43195850-E5543F0E-38D3-4655-B767-80EECF6ECE87Q46923243-65C286DB-BD7B-4404-A649-D56C671BFC29Q47133616-69516D85-3843-44CF-83CB-F75A342221DBQ47563507-4073A744-39D2-4F84-B9E4-618408103E4EQ47745924-FE7ABBF7-8A1F-48B8-8EDE-DDE387B749A0Q48130724-0E1DD671-0120-4026-9AF1-9256BCFC5870Q51216532-A614B606-B83A-4E2E-BF39-861A638F647AQ51335122-6B739989-2A31-43A3-B7D9-27412A4A0A83Q51412140-9449D0F3-826A-4067-B0E4-2688F74C54E6Q52336692-D1F11DA5-3300-415B-B0A8-4D395B76043AQ52575994-DE2D1724-FF22-4BAD-A726-FA473E543155Q54518158-60806F03-E409-439D-87CD-13E4CBB402FAQ54959769-5E214A0F-B637-49E4-A1C2-1726667F78A6Q55092989-D7137D4B-720C-4FC1-8084-46E48278283F
P2860
Serum metabolite concentrations and decreased GFR in the general population.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Serum metabolite concentrations and decreased GFR in the general population.
@en
Serum metabolite concentrations and decreased GFR in the general population.
@nl
type
label
Serum metabolite concentrations and decreased GFR in the general population.
@en
Serum metabolite concentrations and decreased GFR in the general population.
@nl
prefLabel
Serum metabolite concentrations and decreased GFR in the general population.
@en
Serum metabolite concentrations and decreased GFR in the general population.
@nl
P2093
P50
P1476
Serum metabolite concentrations and decreased GFR in the general population.
@en
P2093
Angela Döring
Anna Köttgen
Guangju Zhai
Jerzy Adamski
Margit Heier
Oemer-Necmi Goek
P304
P356
10.1053/J.AJKD.2012.01.014
P50
P577
2012-03-30T00:00:00Z